Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20220223054106N1
IRCT20220223054106N1
Not yet recruiting
Phase 3

Evaluation of the effectiveness of cream containing Rhaphanus sativus seed extract in treatment of women with facial melasma - A triple blind clinical trial

Tehran University of Medical Sciences0 sites25 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
25
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Clinical diagnosis of melasma by a dermatologist (at the Center for Dermatology and Leprosy Research)
  • •Female gender
  • •Age of over 18 years
  • •Bilateral facial melasma

Exclusion Criteria

  • •Pregnancy and breastfeeding
  • •Use of any topical treatment for melasma during 2 months before the start of the study
  • •Taking oral contraceptives and hormonal drugs for 4 weeks before the study
  • •Use of drugs that increase sensitivity to sunlight; Such as doxycycline, minocycline, tetracycline, ciprofloxacin, hydrochlorothiazide and sulfonamides
  • •The presence of scars, tattoos, excessive hair, or any other condition that makes the test site less likely to be evaluated

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Effect of Chelidonium majus and hyoscyamus niger with propolis on psoriasis
IRCT20200516047462N4Kashan University of Medical Sciences88
Completed
Phase 2
To evaluate the efficacy of antiageing cream.
CTRI/2017/12/011027Dabur India Ltd32
Completed
Phase 3
Effect of topical cream ,containing Tragacanth on the Eczema and it’s comparison with Mometasone 0.1%
IRCT20190914044767N1Traditional Medicine & Materia Medica Research center Shahid Beheshti university of Medical Sciences42
Active, not recruiting
Phase 1
Assessment of the activity of a new cream containing betamethasone dipropionate at 0.010%, 0.025% and 0.050% versus reference products using a vasoconstriction assay in healthy subjects.Topical treatment of inflammatory dermatosis linked to cutaneous dryness
EUCTR2008-007173-20-FRPierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre40
Recruiting
Phase 3
Efficacy and safety evaluation of the cream including Citystem extract and Phytessence extract on reducing skin damage caused by air pollutioSkin damage caused by air pollution.
IRCT20161207031288N14Tehran University of Medical Sciences26